Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML).

Medical oncology (Northwood, London, England) - 1 Sept 2014

Aref Salah, El-Ghonemy Mohamed Sabry, Abouzeid Tarek Elsayed, El-Sabbagh Amr Mohamed, El-Baiomy Mohamed Ali

Abstract excerpt

This study aimed to evaluate the incidence and clinical and prognostic impact of TERT A1062T mutation in AML patients treated at Mansoura Oncology Center. Screening for TERT A1062T mutation in exon 15 of the TERT gene was performed on diagnostic DNA samples from 153 AML patients and 197 healthy subjects as a control group by using sequence-specific primers. TERT A1062T mutation was detected in 18 cases out of 153...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Egypt

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Prevalence

Share to Recurrence

Share to Survival Analysis

Share to Telomerase

Share to Treatment Outcome

Source

Identifiers

PMID: 25108601
DOI: 10.1007/s12032-014-0158-6

Genes

TERT

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML).PMID 25108601Read ↗

The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.Semantic proximity Read ↗

TERT Genotype Polymorphism: A Glance of Change Egyptian MDS Outcomes.Semantic proximity Read ↗

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.Semantic proximity Read ↗

Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.Semantic proximity Read ↗

TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia.Semantic proximity Read ↗

TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemiaSemantic proximity Read ↗

Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, IndiaSemantic proximity Read ↗

Novel telomerase reverse transcriptase gene mutation in a family with aplastic anaemia.Semantic proximity Read ↗

[Association of WT1 rs16754 polymorphism with clinical features and prognosis in patients with acute myeloid leukemia].Semantic proximity Read ↗

Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients.Semantic proximity Read ↗

Telomerase activity and the expression of telomerase components in acute myelogenous leukaemiaSemantic proximity Read ↗

Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.